世界のヘレセプチンバイオシミラー市場レポート2020年

【英語タイトル】Global Hereceptin Biosimilars Sales Market Report 2020

QYResearchが出版した調査資料(QYR20JN05763)・商品コード:QYR20JN05763
・発行会社(調査会社):QYResearch
・発行日:2020年6月
・ページ数:135
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥630,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のヘレセプチンバイオシミラー市場について種類別(カプセル、錠剤、その他)、用途別(医療・医薬品、パーソナルケア、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ヘレセプチンバイオシミラー市場の概要
・世界の主要地域別ヘレセプチンバイオシミラー市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のヘレセプチンバイオシミラー市場規模2015-2026:種類別(カプセル、錠剤、その他)
・世界のヘレセプチンバイオシミラー市場規模2015-2026:用途別(医療・医薬品、パーソナルケア、その他)
・ヘレセプチンバイオシミラーの北米市場規模2015-2020
・ヘレセプチンバイオシミラーのヨーロッパ市場規模2015-2020
・ヘレセプチンバイオシミラーの中国市場規模2015-2020
・ヘレセプチンバイオシミラーの日本市場規模2015-2020
・ヘレセプチンバイオシミラーの東南アジア市場規模2015-2020
・ヘレセプチンバイオシミラーのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Mylan N.V、Amgen Inc.、Mabion S.A.、AryoGen Biopharma、Genor Biopharma、Celltrion Inc.、Gedeon Richter、The Instituto Vital Brazil、F. Hoffmann-La Roche AG、Biocons)
・ヘレセプチンバイオシミラーの製造コスト分析
・販売チャネル、流通業者、顧客
・ヘレセプチンバイオシミラーの市場動向・機会・課題
・調査の結論
【レポートの概要】

Herceptin, also known as trastuzumab, is used as a medication for patients who suffer from cancer, which assists in controlling the growth and spread of cancer cells in the body. Herceptin biosimilars are essentially used to treat certain breast as well stomach cancers, and is also used in combination with other medicines for treatment.

Market Analysis and Insights: Global Hereceptin Biosimilars Market
The global Hereceptin Biosimilars market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Hereceptin Biosimilars Scope and Market Size
The global Hereceptin Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereceptin Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hereceptin Biosimilars market is segmented into
Capsule
Tablet
Others

Segment by Application, the Hereceptin Biosimilars market is segmented into
Healthcare & Pharmaceuticals
Personal Care
Others
The Hereceptin Biosimilars market is analysed and market size information is provided by regions (countries). Segment by Application, the Hereceptin Biosimilars market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hereceptin Biosimilars Market Share Analysis
Hereceptin Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereceptin Biosimilars business, the date to enter into the Hereceptin Biosimilars market, Hereceptin Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Mylan N.V
Amgen Inc.
Mabion S.A.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Gedeon Richter
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocons

【レポートの目次】

Table of Contents

1 Hereceptin Biosimilars Market Overview
1.1 Hereceptin Biosimilars Product Scope
1.2 Hereceptin Biosimilars Segment by Type
1.2.1 Global Hereceptin Biosimilars Sales by Type (2020-2026)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Others
1.3 Hereceptin Biosimilars Segment by Application
1.3.1 Global Hereceptin Biosimilars Sales Comparison by Application (2020-2026)
1.3.2 Healthcare & Pharmaceuticals
1.3.3 Personal Care
1.3.4 Others
1.4 Hereceptin Biosimilars Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hereceptin Biosimilars Sales Growth Rate (2015-2026)
1.4.2 Global Hereceptin Biosimilars Revenue and Growth Rate (2015-2026)
1.4.3 Global Hereceptin Biosimilars Price Trends (2015-2026)

2 Hereceptin Biosimilars Estimate and Forecast by Region
2.1 Global Hereceptin Biosimilars Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hereceptin Biosimilars Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hereceptin Biosimilars Sales Market Share by Region (2015-2020)
2.2.2 Global Hereceptin Biosimilars Revenue Market Share by Region (2015-2020)
2.3 Global Hereceptin Biosimilars Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hereceptin Biosimilars Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hereceptin Biosimilars Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hereceptin Biosimilars Estimates and Projections (2015-2026)
2.4.2 Europe Hereceptin Biosimilars Estimates and Projections (2015-2026)
2.4.3 China Hereceptin Biosimilars Estimates and Projections (2015-2026)
2.4.4 Japan Hereceptin Biosimilars Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hereceptin Biosimilars Estimates and Projections (2015-2026)
2.4.6 India Hereceptin Biosimilars Estimates and Projections (2015-2026)
3 Global Hereceptin Biosimilars Competition Landscape by Players
3.1 Global Top Hereceptin Biosimilars Players by Sales (2015-2020)
3.2 Global Top Hereceptin Biosimilars Players by Revenue (2015-2020)
3.3 Global Hereceptin Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilars as of 2019)
3.4 Global Hereceptin Biosimilars Average Price by Company (2015-2020)
3.5 Manufacturers Hereceptin Biosimilars Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hereceptin Biosimilars Players (Opinion Leaders)
4 Global Hereceptin Biosimilars Market Size by Type
4.1 Global Hereceptin Biosimilars Historic Market Review by Type (2015-2020)
4.1.1 Global Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
4.1.2 Global Hereceptin Biosimilars Revenue Market Share by Type (2015-2020)
4.1.3 Global Hereceptin Biosimilars Price by Type (2014-2020)
4.2 Global Hereceptin Biosimilars Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hereceptin Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Hereceptin Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Global Hereceptin Biosimilars Price Forecast by Type (2021-2026)
5 Global Hereceptin Biosimilars Market Size by Application
5.1 Global Hereceptin Biosimilars Historic Market Review by Application (2015-2020)
5.1.1 Global Hereceptin Biosimilars Sales Market Share by Application (2015-2020)
5.1.2 Global Hereceptin Biosimilars Revenue Market Share by Application (2015-2020)
5.1.3 Global Hereceptin Biosimilars Price by Application (2015-2020)
5.2 Global Hereceptin Biosimilars Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hereceptin Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Hereceptin Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereceptin Biosimilars Price Forecast by Application (2021-2026)

3 North America Hereceptin Biosimilars Market Facts & Figures
3.2 North America Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
3.3 North America Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
3.4 North America Hereceptin Biosimilars Sales Market Share by Application (2015-2020)

4 Europe Hereceptin Biosimilars Market Facts & Figures
4.2 Europe Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
4.3 Europe Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
4.4 Europe Hereceptin Biosimilars Sales Market Share by Application (2015-2020)

5 China Hereceptin Biosimilars Market Facts & Figures
5.2 China Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
5.3 China Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
5.4 China Hereceptin Biosimilars Sales Market Share by Application (2015-2020)

6 Japan Hereceptin Biosimilars Market Facts & Figures
6.2 Japan Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
6.3 Japan Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
6.4 Japan Hereceptin Biosimilars Sales Market Share by Application (2015-2020)

7 Southeast Asia Hereceptin Biosimilars Market Facts & Figures
7.2 Southeast Asia Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hereceptin Biosimilars Sales Market Share by Application (2015-2020)

8 India Hereceptin Biosimilars Market Facts & Figures
8.2 India Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
8.3 India Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
8.4 India Hereceptin Biosimilars Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Hereceptin Biosimilars Business
12.1 Mylan N.V
12.1.1 Mylan N.V Hereceptin Biosimilars Corporation Information
12.1.2 Mylan N.V Hereceptin Biosimilars Business Overview and Total Revenue
12.1.3 Mylan N.V Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Mylan N.V Hereceptin Biosimilars Products Offered
12.1.5 Mylan N.V Recent Development
12.2 Amgen Inc.
12.2.1 Amgen Inc. Hereceptin Biosimilars Corporation Information
12.2.2 Amgen Inc. Hereceptin Biosimilars Business Overview and Total Revenue
12.2.3 Amgen Inc. Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Inc. Hereceptin Biosimilars Products Offered
12.2.5 Amgen Inc. Recent Development
12.3 Mabion S.A.
12.3.1 Mabion S.A. Hereceptin Biosimilars Corporation Information
12.3.2 Mabion S.A. Hereceptin Biosimilars Business Overview and Total Revenue
12.3.3 Mabion S.A. Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mabion S.A. Hereceptin Biosimilars Products Offered
12.3.5 Mabion S.A. Recent Development
12.4 AryoGen Biopharma
12.4.1 AryoGen Biopharma Hereceptin Biosimilars Corporation Information
12.4.2 AryoGen Biopharma Hereceptin Biosimilars Business Overview and Total Revenue
12.4.3 AryoGen Biopharma Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AryoGen Biopharma Hereceptin Biosimilars Products Offered
12.4.5 AryoGen Biopharma Recent Development
12.5 Genor Biopharma
12.5.1 Genor Biopharma Hereceptin Biosimilars Corporation Information
12.5.2 Genor Biopharma Hereceptin Biosimilars Business Overview and Total Revenue
12.5.3 Genor Biopharma Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Genor Biopharma Hereceptin Biosimilars Products Offered
12.5.5 Genor Biopharma Recent Development
12.6 Celltrion Inc.
12.6.1 Celltrion Inc. Hereceptin Biosimilars Corporation Information
12.6.2 Celltrion Inc. Hereceptin Biosimilars Business Overview and Total Revenue
12.6.3 Celltrion Inc. Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Celltrion Inc. Hereceptin Biosimilars Products Offered
12.6.5 Celltrion Inc. Recent Development
12.7 Gedeon Richter
12.7.1 Gedeon Richter Hereceptin Biosimilars Corporation Information
12.7.2 Gedeon Richter Hereceptin Biosimilars Business Overview and Total Revenue
12.7.3 Gedeon Richter Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Gedeon Richter Hereceptin Biosimilars Products Offered
12.7.5 Gedeon Richter Recent Development
12.8 The Instituto Vital Brazil
12.8.1 The Instituto Vital Brazil Hereceptin Biosimilars Corporation Information
12.8.2 The Instituto Vital Brazil Hereceptin Biosimilars Business Overview and Total Revenue
12.8.3 The Instituto Vital Brazil Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.8.4 The Instituto Vital Brazil Hereceptin Biosimilars Products Offered
12.8.5 The Instituto Vital Brazil Recent Development
12.9 F. Hoffmann-La Roche AG
12.9.1 F. Hoffmann-La Roche AG Hereceptin Biosimilars Corporation Information
12.9.2 F. Hoffmann-La Roche AG Hereceptin Biosimilars Business Overview and Total Revenue
12.9.3 F. Hoffmann-La Roche AG Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.9.4 F. Hoffmann-La Roche AG Hereceptin Biosimilars Products Offered
12.9.5 F. Hoffmann-La Roche AG Recent Development
12.10 Biocons
12.10.1 Biocons Hereceptin Biosimilars Corporation Information
12.10.2 Biocons Hereceptin Biosimilars Business Overview and Total Revenue
12.10.3 Biocons Hereceptin Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Biocons Hereceptin Biosimilars Products Offered
12.10.5 Biocons Recent Development

13 Hereceptin Biosimilars Manufacturing Cost Analysis
13.1 Hereceptin Biosimilars Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereceptin Biosimilars
13.4 Hereceptin Biosimilars Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereceptin Biosimilars Distributors List
14.3 Hereceptin Biosimilars Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Hereceptin Biosimilars Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Hereceptin Biosimilars Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Hereceptin Biosimilars Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Hereceptin Biosimilars Sales (K MT) by Region (2015-2020)
Table 5. Global Hereceptin Biosimilars Sales Market Share by Region (2015-2020)
Table 6. Global Hereceptin Biosimilars Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Hereceptin Biosimilars Revenue Share by Region (2015-2020)
Table 8. Global Hereceptin Biosimilars Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Hereceptin Biosimilars Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Hereceptin Biosimilars Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Hereceptin Biosimilars Revenue Share Forecast by Region (2021-2026)
Table 12. Global Hereceptin Biosimilars (K MT) of Key Companies (2015-2020)
Table 13. Global Hereceptin Biosimilars Sales Share by Company (2015-2020)
Table 14. Global Hereceptin Biosimilars Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Hereceptin Biosimilars Revenue Share by Company (2015-2020)
Table 16. Global Hereceptin Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilars as of 2019)
Table 17. Global Hereceptin Biosimilars Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Hereceptin Biosimilars Manufacturing Sites and Area Served
Table 19. Manufacturers Hereceptin Biosimilars Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Hereceptin Biosimilars Players
Table 22. Global Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 23. Global Hereceptin Biosimilars Sales Share by Type (2015-2020)
Table 24. Global Hereceptin Biosimilars Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Hereceptin Biosimilars Price (K MT) by Type (2015-2020)
Table 26. Global Hereceptin Biosimilars Sales Share by Type (2021-2026)
Table 27. Global Hereceptin Biosimilars Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Hereceptin Biosimilars Revenue Share by Type (2021-2026)
Table 29. Global Hereceptin Biosimilars Price (K MT) by Type (2021-2026)
Table 30. Global Hereceptin Biosimilars Sales (K MT) by Application (2015-2020)
Table 31. Global Hereceptin Biosimilars Sales Share by Application (2015-2020)
Table 32. Global Hereceptin Biosimilars Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Hereceptin Biosimilars Price (K MT) by Application (2015-2020)
Table 34. Global Hereceptin Biosimilars Sales (K MT) by Application (2021-2026)
Table 35. Global Hereceptin Biosimilars Sales Share by Application (2021-2026)
Table 36. Global Hereceptin Biosimilars Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Hereceptin Biosimilars Revenue Share by Application (2021-2026)
Table 38. Global Hereceptin Biosimilars Price (K MT) by Application (2021-2026)
Table 39. United States Hereceptin Biosimilars Sales (K MT) by Company (2015-2020)
Table 40. United States Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
Table 41. United States Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 42. United States Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 43. United States Hereceptin Biosimilars Sales (K MT) by Application (2015-2020)
Table 44. United States Hereceptin Biosimilars Sales Market Share by Application (2015-2020)
Table 45. Europe Hereceptin Biosimilars Sales (K MT) by Company (2015-2020)
Table 46. Europe Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
Table 47. Europe Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 48. Europe Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 49. Europe Hereceptin Biosimilars Sales (K MT) by Application (2015-2020)
Table 50. Europe Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 51. China Hereceptin Biosimilars Sales (K MT) by Company (2015-2020)
Table 52. China Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
Table 53. China Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 54. China Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 55. China Hereceptin Biosimilars Sales (K MT) by Application (2015-2020)
Table 56. China Hereceptin Biosimilars Sales Market Share by Application (2015-2020)
Table 57. Japan Hereceptin Biosimilars Sales (K MT) by Company (2015-2020)
Table 58. Japan Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
Table 59. Japan Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 60. Japan Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 61. Japan Hereceptin Biosimilars Sales (K MT) by Application (2015-2020)
Table 62. Japan Hereceptin Biosimilars Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Hereceptin Biosimilars Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Hereceptin Biosimilars Sales Market Share by Application (2015-2020)
Table 69. India Hereceptin Biosimilars Sales (K MT) by Company (2015-2020)
Table 70. India Hereceptin Biosimilars Sales Market Share by Company (2015-2020)
Table 71. India Hereceptin Biosimilars Sales (K MT) by Type (2015-2020)
Table 72. India Hereceptin Biosimilars Sales Market Share by Type (2015-2020)
Table 73. India Hereceptin Biosimilars Sales (K MT) by Application (2015-2020)
Table 74. India Hereceptin Biosimilars Sales Market Share by Application (2015-2020)
Table 75. Mylan N.V Corporation Information
Table 76. Mylan N.V Description and Business Overview
Table 77. Mylan N.V Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Mylan N.V Hereceptin Biosimilars Product
Table 79. Mylan N.V Recent Development
Table 80. Amgen Inc. Corporation Information
Table 81. Amgen Inc. Description and Business Overview
Table 82. Amgen Inc. Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Amgen Inc. Hereceptin Biosimilars Product
Table 84. Amgen Inc. Recent Development
Table 85. Mabion S.A. Corporation Information
Table 86. Mabion S.A. Description and Business Overview
Table 87. Mabion S.A. Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Mabion S.A. Hereceptin Biosimilars Product
Table 89. Mabion S.A. Recent Development
Table 90. AryoGen Biopharma Corporation Information
Table 91. AryoGen Biopharma Description and Business Overview
Table 92. AryoGen Biopharma Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. AryoGen Biopharma Hereceptin Biosimilars Product
Table 94. AryoGen Biopharma Recent Development
Table 95. Genor Biopharma Corporation Information
Table 96. Genor Biopharma Description and Business Overview
Table 97. Genor Biopharma Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Genor Biopharma Hereceptin Biosimilars Product
Table 99. Genor Biopharma Recent Development
Table 100. Celltrion Inc. Corporation Information
Table 101. Celltrion Inc. Description and Business Overview
Table 102. Celltrion Inc. Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Celltrion Inc. Hereceptin Biosimilars Product
Table 104. Celltrion Inc. Recent Development
Table 105. Gedeon Richter Corporation Information
Table 106. Gedeon Richter Description and Business Overview
Table 107. Gedeon Richter Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Gedeon Richter Hereceptin Biosimilars Product
Table 109. Gedeon Richter Recent Development
Table 110. The Instituto Vital Brazil Corporation Information
Table 111. The Instituto Vital Brazil Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. The Instituto Vital Brazil Description and Business Overview
Table 113. The Instituto Vital Brazil Hereceptin Biosimilars Product
Table 114. The Instituto Vital Brazil Recent Development
Table 115. F. Hoffmann-La Roche AG Corporation Information
Table 116. F. Hoffmann-La Roche AG Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. F. Hoffmann-La Roche AG Description and Business Overview
Table 118. F. Hoffmann-La Roche AG Hereceptin Biosimilars Product
Table 119. F. Hoffmann-La Roche AG Recent Development
Table 120. Biocons Corporation Information
Table 121. Biocons Description and Business Overview
Table 122. Biocons Hereceptin Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Biocons Hereceptin Biosimilars Product
Table 124. Biocons Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Hereceptin Biosimilars Distributors List
Table 128. Hereceptin Biosimilars Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereceptin Biosimilars Product Picture
Figure 2. Global Hereceptin Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hereceptin Biosimilars Market Share by Application in 2020 & 2026
Figure 6. Healthcare & Pharmaceuticals Examples
Figure 7. Personal Care Examples
Figure 8. Others Examples
Figure 9. Global Hereceptin Biosimilars Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Hereceptin Biosimilars Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hereceptin Biosimilars Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Hereceptin Biosimilars Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hereceptin Biosimilars Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hereceptin Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hereceptin Biosimilars Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Hereceptin Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hereceptin Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hereceptin Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hereceptin Biosimilars Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hereceptin Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hereceptin Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hereceptin Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hereceptin Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hereceptin Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hereceptin Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hereceptin Biosimilars Players Market Share by Revenue in Hereceptin Biosimilars 2015 & 2019
Figure 27. Hereceptin Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hereceptin Biosimilars Revenue Share by Type (2015-2020)
Figure 29. Global Hereceptin Biosimilars Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hereceptin Biosimilars Revenue Share by Application (2015-2020)
Figure 31. Global Hereceptin Biosimilars Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 33. United States Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 34. Europe Hereceptin Biosimilars Sales Market Share by Company in 2019
Figure 35. Europe Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 36. Europe Hereceptin Biosimilars Sales Market Share by Application in 2019
Figure 37. China Hereceptin Biosimilars Sales Market Share by Company in 2019
Figure 38. China Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 39. China Hereceptin Biosimilars Sales Market Share by Application in 2019
Figure 40. Japan Hereceptin Biosimilars Sales Market Share by Company in 2019
Figure 41. Japan Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 42. Japan Hereceptin Biosimilars Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hereceptin Biosimilars Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hereceptin Biosimilars Sales Market Share by Application in 2019
Figure 46. India Hereceptin Biosimilars Sales Market Share by Company in 2019
Figure 47. India Hereceptin Biosimilars Sales Market Share by Type in 2019
Figure 48. India Hereceptin Biosimilars Sales Market Share by Application in 2019
Figure 49. Mylan N.V Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mabion S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AryoGen Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Genor Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Celltrion Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Gedeon Richter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. The Instituto Vital Brazil Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. F. Hoffmann-La Roche AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Biocons Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Hereceptin Biosimilars
Figure 61. Manufacturing Process Analysis of Hereceptin Biosimilars
Figure 62. Hereceptin Biosimilars Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Mylan N.V、Amgen Inc.、Mabion S.A.、AryoGen Biopharma、Genor Biopharma、Celltrion Inc.、Gedeon Richter、The Instituto Vital Brazil、F. Hoffmann-La Roche AG、Biocons

【レポートのキーワード】

ヘレセプチンバイオシミラー、カプセル、錠剤、医療・医薬品、パーソナルケア

★調査レポート[世界のヘレセプチンバイオシミラー市場レポート2020年] (コード:QYR20JN05763)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヘレセプチンバイオシミラー市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆